Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience

Multiple Sclerosis Journal

Volumn 18, Issue 6, 2012, Pages 835-842

  Mancardi, G L ^a   Sormani, M P ^a   Di Gioia, M ^b   Vuolo, L ^b   Gualandi, F ^c   Amato, M P ^b   Capello, E ^a   Curro D ^a   Uccelli, A ^a   Bertolotto, A ^d   Gasperini, C ^e   Lugaresi, A ^f   Merelli, E ^g   Meucci, G ^h   Motti, L ⁱ   Tola, M R ^j   Scarpini, E ^k   Repice, A M ^b   Massacesi, L ^b   Saccardi, R ^b   Donnini, I ^l   Bosi, A ^l   Guidi, S ^l   Bagigalupo, A ^l   Bonzano, L ^l   Bruzzi, P ^l   Roccatagliata, L ^l   Antenucci, R ^l   Granella, F ^l   Martino, G ^l   Rottoli, M ^l   Solaro, C ^m   Salvi, F ^l   Ursino, E ^l   Barilaro, A ^l   Capobianco, M ^l   more..

^a UNIVERSITY OF GENOA   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d SAN LUIGI GONZAGA HOSPITAL   (Italy)

^e SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

^g UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^h Livorno Hospital   (Italy)

ⁱ S MARIA NUOVA HOSPITAL   (Italy)

^j UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

^l Ferrara Hospital ^*  (Italy)

^m University of Milan ^*  (Italy)

more..

Author keywords

bone marrow transplantation; haematopoietic stem cell transplantation; multiple sclerosis

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN HEMORRHAGE; CYTOMEGALOVIRUS; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FOLLOW UP; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MORTALITY; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; RELAPSE; SEPSIS; SYNCOPE; TREATMENT OUTCOME; URINARY TRACT INFECTION; VIRUS REACTIVATION; WERNICKE ENCEPHALOPATHY;

EID: 84861811380     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511429320     Document Type: Article

References (33)

1. Ikehara S, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A. 1985 ; 82: 2483-2487
2. Marmont AM, Van Bekkum DW. Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant. 1995 ; 16: 497-498
3. van Gelder M, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain. Bone Marrow Transplant. 1995 ; 16: 343-351
4. van Gelder M, Mulder AH, van Bekkum DW. Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation. 1996 ; 62: 810-818
5. Binks M, Passweg JR, Furst D, et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis. 2001 ; 60: 577-584
6. Burt RK, Padilla J, Begolka WS, et al. Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood. 1998 ; 91: 2609-2616
7. Farge D, Passweg J, van Laar JM, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis. 2004 ; 63: 974-981
8. Burt RK, Shah SJ, Dill K, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet. 2011 ; 378: 498-506
9. Jayne D, Passweg J, Marmont A, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus. 2004 ; 13: 168-176
10. Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA. 2006 ; 295: 527-535
11. Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet. 1999 ; 353: 550-553
12. Wulffraat NM, van Rooijen EM, Tewarie R, Brinkman D, Prakken B, Kuis W. Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis. Autoimmunity. 2008 ; 41: 632-638
13. Fassas A, Anagnostopoulos A, Kazis A, et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant. 1997 ; 20: 631-638
14. Saccardi R, Kozak T, Bocelli-Tyndall C, et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler. 2006 ; 12: 814-823
15. Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 2008 ; 7: 626-636
16. Atkins H. Hematopoietic SCT for the treatment of multiple sclerosis. Bone Marrow Transplant. 2010 ; 45: 1671-1681
17. Reston JT, Uhl S, Treadwell JR, Nash RA, Schoelles K. Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review. Mult Scler. 2011 ; 17: 204-213
18. Pasquini MC, Griffith LM, Arnold DL, et al. Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. Biol Blood Marrow Transplant. 2010 ; 16: 1076-1083
19. Kozák T, Havrdová E, Pit'ha J, et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant. 2000 ; 25: 525-531
20. Burt RK, Cohen BA, Russell E, et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood. 2003 ; 102: 2373-2378
21. Carreras E, Saiz A, Marín P, et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica. 2003 ; 88: 306-314
22. Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood. 2003 ; 102: 2364-2372
23. Saccardi R, Mancardi GL, Solari A, et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood. 2005 ; 105: 2601-2607
24. Mancardi GL, Saccardi R, Filippi M, et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology. 2001 ; 57: 62-68
25. Snowden J, Saccardi R, Allez M, et al. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2011 ;:
26. Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica. 2010 ; 95: 284-292
27. Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005 ; 35: 869-879
28. Radaelli M, Moiola L, Martinelli V, et al. Autologous hematopoietic stem cell transplantation with Thiotepa-Cyclophosphamide conditioning in aggressive multiple sclerosis: clinical and MRI follow up in eight patients. Neurol Sci. 2008 ; 29: S319
29. Mancardi GL, Gualandi F, et al. A prospective clinical and MRI study of a low intensity conditioning regimen followed by autologous hematopoietic stem cell transplantation in severe multiple sclerosis. Mult Scler. 2009 ; 15: S253
30. Coles AJ, Cox A, Le Page E, et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol. 2006 ; 253: 98-108
31. Burt RK, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol. 2009 ; 8: 244-253
32. Krasulová E, Trneny M, Kozák T, et al. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Mult Scler. 2010 ; 16: 685-693
33. Fassas A, Kimiskidis VK, Sakellari I, et al. Long-term results of stem cell transplantation for MS: a single-center experience. Neurology. 2011 ; 76: 1066-1070